The short version of PPARδ agonist fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-07 and is reviewed periodically as new material appears.
In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.
Cardarine is a common name for GW501516, a synthetic compound developed in the 1990s through research collaborations involving GlaxoSmithKline. It belongs to a class of molecules known as peroxisome proliferator-activated receptor delta agonists. Early studies explored its effects on lipid metabolism and energy expenditure in animal models. The compound was never approved as a human medicine, and clinical development was discontinued. In the years since, it has appeared in fitness and bodybuilding communities as a performance-enhancing substance. Regulatory agencies classify it as an unapproved drug.
PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
| Property | Value | Notes |
|---|---|---|
| CAS Registry Number | 317318-70-0 | Unique identifier for the compound. |
| Chemical class | PPARδ agonist | Synthetic ligand for peroxisome proliferator-activated receptor delta. |
| Appearance | White to off-white solid | Typical form of research-grade material. |
| Solubility | Soluble in DMSO and ethanol | Poorly soluble in water. |
| Typical storage | -20°C | Recommended for long-term storage of stock solutions. |
PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.
Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.
Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.
Published literature on cardarine includes in vitro assays, rodent experiments, and a small number of human studies. Reports describe effects on exercise capacity and lipid metabolism in animals, while human evidence is sparse. Many online descriptions present the compound as a proven endurance aid, a claim not supported by regulatory approval or large clinical trials. Analytical studies focus on identifying the parent compound and its metabolites in biological samples. Important uncertainties include species differences, dose-response relationships, and the relevance of rodent tumor findings to humans.
Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.
A multitude of languages are used by Canadians, with English and French (the official languages) being the mother tongues of approximately 54 percent and 19 percent of Canadians, respectively. Canada's official bilingualism policies give citizens the right to receive federal government services in either English or French with official-language minorities guaranteed their own schools in all provinces and territories. Quebec's 1974 Official Language Act established French as the only official language of the province. Although more than 82 percent of French-speaking Canadians live in Quebec, there are substantial Francophone populations in New Brunswick, Alberta, and Manitoba, with Ontario having the largest French-speaking population outside Quebec. New Brunswick, the only officially bilingual province, has an Acadian French minority constituting 33 percent of the population. There are also clusters of Acadians in southwestern Nova Scotia, on Cape Breton Island, and in central and western Prince Edward Island. Other provinces have no official languages as such, but French is used as a language of instruction, in courts, and for other government services, in addition to English. Manitoba, Ontario, and Quebec allow for both English and French to be spoken in the provincial legislatures and laws are enacted in both languages. In Ontario, French has some legal status, but is not fully co-official. There are 11 Indigenous language groups, composed of more than 65 distinct languages and dialects. Several Indigenous languages have official status in the Northwest Territories.
Adverse reaction Adverse event Adverse drug reaction Biosecurity Biosecurity in the United States Drug Efficacy Study Implementation Food and Drug Administration Modernization Act of 1997 FDA Food Safety Modernization Act of 2011 FDA Fast Track Development Program (for drugs) Food and Drug Administration Amendments Act of 2007 (e.g. drugs) Food and Drug Administration Safety and Innovation Act of 2012 (GAIN/QIDP etc.) Inverse benefit law Investigational Device Exemption (for use in clinical trials) Kefauver Harris Amendment 1962 – required "proof-of-efficacy" for drugs International:
This latest advance, the novel secondary ion mass spectrometry–surface saturation (SIMS-SS), thus, involves modelling the hydrogen concentration profile of the surface versus depth, whereas the age determination is reached via equations describing the diffusion process, while topographical effects have been confirmed and monitored through atomic force microscopy.
In 1989, the communist governments in Poland and Hungary became the first to negotiate the organization of competitive elections. In Czechoslovakia and East Germany, mass protests unseated entrenched communist leaders. The communist regimes in Bulgaria and Romania also crumbled, in the latter case as the result of a violent uprising. Attitudes had changed enough that US Secretary of State James Baker suggested that the American government would not be opposed to Soviet intervention in Romania, on behalf of the opposition, to prevent bloodshed. The tidal wave of change culminated with the fall of the Berlin Wall in November 1989, which symbolized the collapse of European communist governments and graphically ended the Iron Curtain divide of Europe. The 1989 revolutionary wave swept across Central and Eastern Europe and peacefully overthrew all of the Soviet-style Marxist–Leninist states: East Germany, Poland, Hungary, Czechoslovakia and Bulgaria; Romania was the only Eastern-bloc country to topple its communist regime violently and execute its head of state.
The Patrol Ration Pac (PRP) is a shelf-stable product that provides an efficient, flexible and nutritionally robust feeding method. The PRP is designed to cover activities when you have access to other food sources during the day and is ideal to replace a single meal or provide snack options. The PRP provides approximately one-third of the energy and nutrient requirements of most military personnel during moderate, prolonged-intensity physical activity, in a temperate environment. Therefore, it is desirable that all of the food in the pack is eaten. Menus A, B and C contain main meals that can be heated using a flameless ration heater along with other ready to eat foods and a beverage powder. Menu D provides ready to eat snack foods and no beverage powder.
Sources: en.wikipedia.org
=== Pest control === Diatomite is of value as an insecticide because of its abrasive and physico-sorptive properties. The fine powder adsorbs lipids from the waxy outer layer of the exoskeletons of many species of insects. This layer acts as a barrier that resists the loss of water vapour from the insect's body. Damaging the layer increases the evaporation of water from their bodies, so that they dehydrate, often fatally. This also works against gastropods and is commonly employed in gardening to defeat slugs. However, since slugs inhabit humid environments, efficacy is low. Diatomaceous earth is sometimes mixed with an attractant or other additives to increase its effectiveness. The shape of diatoms has not been proven to affect their functionality as regarding adsorption of lipids. However, certain applications, such as that for slugs and snails, work best when a particularly shaped diatom is used, suggesting that lipid adsorption is not the only factor involved. For example, in the case of slugs and snails, large, spiny diatoms work best to lacerate the epithelium of the mollusk. Diatom shells will work to some degree on the vast majority of animals that undergo ecdysis in shedding cuticle, such as arthropods or nematodes. It also may have other effects on lophotrochozoans, such as mollusks or annelids. Medical-grade diatomite has been studied for its efficacy as a deworming agent in cattle; in both studies cited the groups being treated with diatomaceous earth did not fare any better than control groups.
The calcium ion concentration in the cytosol of the beta cells can also, or additionally, be increased through the activation of phospholipase C resulting from the binding of an extracellular ligand (hormone or neurotransmitter) to a G protein-coupled membrane receptor. Phospholipase C cleaves the membrane phospholipid, phosphatidyl inositol 4,5-bisphosphate, into inositol 1,4,5-trisphosphate and diacylglycerol. Inositol 1,4,5-trisphosphate (IP3) then binds to receptor proteins in the plasma membrane of the endoplasmic reticulum (ER). This allows the release of Ca2+ ions from the ER via IP3-gated channels, which raises the cytosolic concentration of calcium ions independently of the effects of a high blood glucose concentration. Parasympathetic stimulation of the pancreatic islets operates via this pathway to increase insulin secretion into the blood. The significantly increased amount of calcium ions in the cells' cytoplasm causes the release into the blood of previously synthesized insulin, which has been stored in intracellular secretory vesicles. This is the primary mechanism for release of insulin. Other substances known to stimulate insulin release include the amino acids arginine and leucine, parasympathetic release of acetylcholine (acting via the phospholipase C pathway), sulfonylurea, cholecystokinin (CCK, also via phospholipase C), and the gastrointestinally derived incretins, such as glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).
Wright's invention did not lead to any further developments, and diamorphine became popular only after it was independently re-synthesized 23 years later by chemist Felix Hoffmann. Hoffmann was working at Bayer pharmaceutical company in Elberfeld, Germany, and his supervisor Heinrich Dreser instructed him to acetylate morphine with the objective of producing codeine, a constituent of the opium poppy that is pharmacologically similar to morphine but less potent and less addictive. Instead, the experiment produced an acetylated form of morphine one and a half to two times more potent than morphine itself. Hoffmann synthesized heroin on 21 August 1897, just eleven days after he had synthesized aspirin. The head of Bayer's research department reputedly coined the drug's new name of "heroin", based on the German heroisch which means "heroic, strong" (from the ancient Greek word "heros, ήρως"). Bayer scientists were not the first to make heroin, but their scientists discovered ways to make it, and Bayer led the commercialization of heroin. Bayer marketed diacetylmorphine as an over-the-counter drug under the trademark name Heroin. It was developed chiefly as a morphine substitute for cough suppressants that did not have morphine's addictive side-effects. Morphine at the time was a popular recreational drug, and Bayer wished to find a similar but non-addictive substitute to market. However, contrary to Bayer's advertising as a "non-addictive morphine substitute", heroin would soon have one of the highest rates of addiction among its users.
A number of former Wildcats have gone on to pursue successful professional NBA careers (especially during the Lute Olson era), including Gilbert Arenas, Richard Jefferson, Mike Bibby, Jason Terry, Sean Elliott, Damon Stoudamire, Khalid Reeves, Luke Walton, Hassan Adams, Salim Stoudamire, Andre Iguodala, Channing Frye, Brian Williams (later known as Bison Dele), Sean Rooks, Jud Buechler, Michael Dickerson, Chase Budinger, Jordan Hill, Jerryd Bayless, Derrick Williams, Kadeem Allen, Aaron Gordon, Solomon Hill, Rondae Hollis-Jefferson, Stanley Johnson, T.J McConnell, Lauri Elias Markkanen, Kobi Simmons, Steve Kerr, Deandre Ayton, Rawle Alkins, and Allonzo Trier. Kenny Lofton, now best known as a former Major League Baseball star, was a four-year letter winner as a Wildcat basketball player (and was on the 1988 Final Four team), before one year on the Arizona baseball team. Another notable former Wildcat basketball player is Eugene Edgerson, who played on the 1997 and 2001 Final Four squads, and spent some of his professional careers as one of the Harlem Globetrotters as "Wildkat" Edgerson.
Sources: en.wikipedia.org
Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.
No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.
Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.
No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.